Original BioMedicals Co., Ltd. (TPEX:6483)
Taiwan · Delayed Price · Currency is TWD 13.70
+0.05 (0.37%)
Aug 19, 2026, 10:51 AM CST
Original BioMedicals Revenue
In the year 2025, Original BioMedicals had annual revenue of 381.00K TWD.
Revenue
381.00K
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
25
Market Cap
908.94M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 381.00K | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 43.00K | -64.00K | -59.81% |
| Dec 31, 2022 | 107.00K | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| TSH Biopharm Corporation | 1.40B |
| Prince Pharmaceutical | 1.22B |
| Excelsior Biopharma | 936.92M |
| Anxo Pharmaceutical | 878.88M |
| DV Biomed | 795.19M |
| GeneFerm Biotechnology | 664.94M |
| Winston Medical Supply | 632.80M |
| General Biologicals | 260.23M |